US judge denies AstraZeneca's bid to vacate approvals for generic Seroquel
This article was originally published in Scrip
Executive Summary
AstraZeneca was straight back into court on March 28, having failed two days earlier to block US generic versions of Seroquel (quetiapine fumarate) (scripintelligence.com, 27 March 2012).